UBS raises Biogen price target to $270 from $240
UBS lifted its Biogen price target to $270.00 per share from $240.00, according to ratings actions reported by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.